{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Alcohol+Hepatitis", "query": { "condition": "Alcohol Hepatitis" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 65, "total_pages": 7, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Alcohol+Hepatitis&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-06-10T19:04:24.235Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03087968", "title": "Evaluation of HepQuant SHUNT to Assess Liver Disease; Substudy Within GS-US-416-2124", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Severe Alcoholic Hepatitis" ], "interventions": [ { "name": "GS-4997", "type": "DRUG" }, { "name": "Prednisolone", "type": "DRUG" }, { "name": "HepQuant SHUNT Test", "type": "DEVICE" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "HepQuant, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 0, "start_date": "2016-07-31", "completion_date": "2017-09-13", "has_results": false, "last_update_posted_date": "2021-08-30", "last_synced_at": "2026-06-10T19:04:24.235Z", "location_count": 13, "location_summary": "Coronado, California • Miami, Florida • Atlanta, Georgia + 9 more", "locations": [ { "city": "Coronado", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Jackson", "state": "Mississippi" } ], "official_url": "https://clinicaltrials.gov/study/NCT03087968" }, { "nct_id": "NCT04563026", "title": "A Phase 2b Study in Subjects With Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 Treatment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alcoholic Hepatitis" ], "interventions": [ { "name": "DUR-928 30 mg", "type": "DRUG" }, { "name": "DUR-928 90 mg", "type": "DRUG" }, { "name": "Placebo+ Standard of Care (SOC)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Durect", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 307, "start_date": "2021-01-22", "completion_date": "2023-09-06", "has_results": false, "last_update_posted_date": "2024-09-05", "last_synced_at": "2026-06-10T19:04:24.235Z", "location_count": 48, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Coronado, California + 33 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Coronado", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04563026" }, { "nct_id": "NCT04072822", "title": "Trial of Anakinra (Plus Zinc) or Prednisone in Patients With Severe Alcoholic Hepatitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alcoholic Hepatitis" ], "interventions": [ { "name": "Anakinra and Zinc", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Placebos", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Indiana University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 147, "start_date": "2020-07-10", "completion_date": "2022-08-12", "has_results": true, "last_update_posted_date": "2025-02-10", "last_synced_at": "2026-06-10T19:04:24.235Z", "location_count": 10, "location_summary": "Phoenix, Arizona • Jacksonville, Florida • Indianapolis, Indiana + 7 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04072822" }, { "nct_id": "NCT06285253", "title": "miroliverELAP® for the Treatment of Acute Liver Failure: A Phase 1 Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Acute Liver Failure", "Acute Liver Injury, Drug Induced", "Acute on Chronic Liver Failure (ACLF)", "Acute Alcoholic Hepatitis" ], "interventions": [ { "name": "miroliverELAP treatment", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "Miromatrix Medical Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 10, "start_date": "2024-10-05", "completion_date": "2026-01-22", "has_results": false, "last_update_posted_date": "2026-03-06", "last_synced_at": "2026-06-10T19:04:24.235Z", "location_count": 8, "location_summary": "Chicago, Illinois • Ann Arbor, Michigan • Minneapolis, Minnesota + 5 more", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06285253" }, { "nct_id": "NCT05832229", "title": "Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cirrhosis", "Cirrhosis, Liver", "Cirrhosis Early", "Cirrhosis Due to Hepatitis B", "Cirrhosis Advanced", "Cirrhosis Infectious", "Cirrhosis Alcoholic", "Cirrhosis Due to Hepatitis C" ], "interventions": [ { "name": "Rosuvastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 256, "start_date": "2023-12-07", "completion_date": "2029-08-31", "has_results": false, "last_update_posted_date": "2026-06-02", "last_synced_at": "2026-06-10T19:04:24.235Z", "location_count": 13, "location_summary": "La Jolla, California • Los Angeles, California • San Francisco, California + 7 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05832229" }, { "nct_id": "NCT01809132", "title": "Efficacy Study of Anakinra, Pentoxifylline, and Zinc Compared to Methylprednisolone in Severe Acute Alcoholic Hepatitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Acute Alcoholic Hepatitis" ], "interventions": [ { "name": "Anakinra", "type": "DRUG" }, { "name": "Pentoxifylline", "type": "DRUG" }, { "name": "Zinc Sulfate", "type": "DRUG" }, { "name": "Methylprednisolone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mack Mitchell", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "21 Years to 70 Years" }, "enrollment_count": 104, "start_date": "2013-09", "completion_date": "2018-10", "has_results": true, "last_update_posted_date": "2021-11-01", "last_synced_at": "2026-06-10T19:04:24.235Z", "location_count": 4, "location_summary": "Louisville, Kentucky • Worcester, Massachusetts • Cleveland, Ohio + 1 more", "locations": [ { "city": "Louisville", "state": "Kentucky" }, { "city": "Worcester", "state": "Massachusetts" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01809132" }, { "nct_id": "NCT00205075", "title": "Impact of Moderate Alcohol Use on Hepatitis C Virus (HCV) Progression", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hepatic Fibrogenesis", "Hepatitis C" ], "interventions": [], "intervention_types": [], "sponsor": "University of Wisconsin, Madison", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 47, "start_date": "2004-08", "completion_date": "2008-06", "has_results": false, "last_update_posted_date": "2015-12-09", "last_synced_at": "2026-06-10T19:04:24.235Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT00205075" }, { "nct_id": "NCT03902366", "title": "HCV and Co-morbid Alcohol Use Disorders: A Translational Investigation of Antiviral Therapy Outcomes on CNS Function", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hepatitis C", "Alcohol Use Disorder" ], "interventions": [ { "name": "Neuropsychological assessment", "type": "DIAGNOSTIC_TEST" }, { "name": "Neuroimaging", "type": "BEHAVIORAL" } ], "intervention_types": [ "DIAGNOSTIC_TEST", "BEHAVIORAL" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 63, "start_date": "2019-05-16", "completion_date": "2023-12-29", "has_results": true, "last_update_posted_date": "2025-03-27", "last_synced_at": "2026-06-10T19:04:24.235Z", "location_count": 1, "location_summary": "Portland, Oregon", "locations": [ { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT03902366" }, { "nct_id": "NCT01476995", "title": "Prognostic Indicators as Provided by the EPIC ClearView", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Coronary Artery Disease", "Congestive Heart Failure", "Valvular Heart Disease", "Atrial Fibrillation", "Hypertension", "Pyelonephritis", "Acute Renal Failure", "Renal Failure", "Viral Hepatitis", "Alcoholic Hepatitis", "Steatohepatitis", "Cirrhosis", "Asthma", "COPD", "Bronchitis", "Emphysema", "Pneumonia", "Inflammatory Bowel Disease", "Crohn's Disease", "Ulcerative Colitis", "Diverticulitis", "Peptic Ulcer Disease", "Irritable Bowel Syndrome", "Cholecystitis", "Pancreatitis", "Malabsorption Disorders", "Celiac Sprue", "Diabetes" ], "interventions": [], "intervention_types": [], "sponsor": "Epic Research & Diagnostics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 353, "start_date": "2010-09", "completion_date": "2011-06", "has_results": false, "last_update_posted_date": "2011-11-22", "last_synced_at": "2026-06-10T19:04:24.235Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01476995" }, { "nct_id": "NCT06750588", "title": "Safety and Tolerability of NTR-101 in Patients With Acute Alcohol-Associated Hepatitis", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Alcohol-Associated Hepatitis" ], "interventions": [ { "name": "bacteriophage preparation", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Nterica Bio inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 12, "start_date": "2025-11-05", "completion_date": "2026-06", "has_results": false, "last_update_posted_date": "2025-08-17", "last_synced_at": "2026-06-10T19:04:24.235Z", "location_count": 1, "location_summary": "Coronado, California", "locations": [ { "city": "Coronado", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06750588" } ] }